Detalles de la búsqueda
1.
Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma.
Invest New Drugs
; 41(5): 761-767, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37721661
2.
Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung Cancer.
Ther Drug Monit
; 45(1): 110-116, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35830878
3.
Pharmacokinetics of Temozolomide in a Patient With Glioblastoma Undergoing Hemodialysis: A Short Communication.
Ther Drug Monit
; 45(6): 823-826, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37646650
4.
Pharmacist-Urologist Collaborative Management for Patients with Renal Cell Carcinoma Receiving Pazopanib Monotherapy.
Biol Pharm Bull
; 46(8): 1065-1071, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532558
5.
Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study.
Int J Clin Oncol
; 28(8): 1054-1062, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37261583
6.
Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score-matched analysis.
Support Care Cancer
; 30(3): 2341-2348, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34738163
7.
Risk Factors of Proteinuria in Patients with Hepatocellular Carcinoma Receiving Lenvatinib.
Biol Pharm Bull
; 45(3): 333-338, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35228399
8.
Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases.
Support Care Cancer
; 29(8): 4763-4772, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33527228
9.
[Consideration on Expiration Days Setting for the Introduction of Drug Vial Optimization].
Gan To Kagaku Ryoho
; 48(9): 1139-1143, 2021 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-34521792
10.
Evaluation of the usefulness of protocol-based pharmacist-facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer.
J Clin Pharm Ther
; 45(6): 1288-1294, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32519774
11.
A simplified method for therapeutic drug monitoring of mitotane by gas chromatography-electron ionization-mass spectrometry.
Biomed Chromatogr
; 34(3): e4776, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31826297
12.
Successful oral desensitization with osimertinib following osimertinib-induced fever and hepatotoxicity: a case report.
Invest New Drugs
; 36(5): 952-954, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29721756
13.
Verification of surface contamination of Japanese cyclophosphamide vials and an example of exposure by handling.
J Oncol Pharm Pract
; 18(2): 201-6, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21947739
14.
Everolimus pharmacokinetics and exposure-response relationship in Japanese patients with advanced breast cancer.
Front Pharmacol
; 13: 984002, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36188563
15.
Risk factors of proteinuria and potentially protective effect of renin-angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib.
Cancer Chemother Pharmacol
; 89(6): 833-838, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35254504
16.
Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide.
Front Pharmacol
; 13: 901099, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35662711
17.
Evaluating the safety and efficiency of robotic dispensing systems.
J Pharm Health Care Sci
; 8(1): 24, 2022 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180937
18.
Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients With Active Cancer.
In Vivo
; 35(5): 2747-2753, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34410964
19.
Safety evaluation of enzalutamide dose-escalation strategy in patients with castration-resistant prostate cancer.
Urol Oncol
; 39(4): 233.e15-233.e20, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32988711
20.
Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases.
Cancer Chemother Pharmacol
; 87(6): 871-877, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33791853